Renal function and non-vitamin K oral anticoagulants in comparison with warfarin on safety and efficacy outcomes in atrial fibrillation patients: a systemic review and meta-regression analysis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Renal function and non-vitamin K oral anticoagulants in comparison with warfarin on safety and efficacy outcomes in atrial fibrillation patients: a systemic review and meta-regression analysis
Authors
Keywords
Renal function, Oral anticoagulants, Meta-analysis, Efficacy, Safety, Atrial fibrillation
Journal
Clinical Research in Cardiology
Volume 104, Issue 5, Pages 418-429
Publisher
Springer Nature
Online
2014-11-22
DOI
10.1007/s00392-014-0797-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparisons between Novel Oral Anticoagulants and Vitamin K Antagonists in Patients with CKD
- (2014) Z. Harel et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Renal Impairment in a “Real-Life” Cohort of Anticoagulated Patients With Atrial Fibrillation (Implications for Thromboembolism and Bleeding)
- (2013) Vanessa Roldán et al. AMERICAN JOURNAL OF CARDIOLOGY
- Safety and Efficacy of Adjusted Dose of Rivaroxaban in Japanese Patients With Non-Valvular Atrial Fibrillation
- (2013) Masatsugu Hori et al. CIRCULATION JOURNAL
- European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation
- (2013) Hein Heidbuchel et al. EUROPACE
- Warfarin or novel oral anticoagulants for atrial fibrillation?
- (2013) Torben Bjerregaard Larsen et al. LANCET
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation
- (2013) Pilar Gallego et al. THROMBOSIS AND HAEMOSTASIS
- General mechanisms of coagulation and targets of anticoagulants (Section I)
- (2013) Steen Husted et al. THROMBOSIS AND HAEMOSTASIS
- Vitamin K antagonists in heart disease: Current status and perspectives (Section III)
- (2013) Raffaele Caterina et al. THROMBOSIS AND HAEMOSTASIS
- Apixaban, an oral, direct factor Xa inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects
- (2012) Charles Frost et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation
- (2012) Masatsugu Hori et al. CIRCULATION JOURNAL
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillation
- (2012) et al. EUROPACE
- Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial
- (2012) Stefan H. Hohnloser et al. EUROPEAN HEART JOURNAL
- Indirect Comparisons of New Oral Anticoagulant Drugs for Efficacy and Safety When Used for Stroke Prevention in Atrial Fibrillation
- (2012) Gregory Y.H. Lip et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease
- (2012) Jonas Bjerring Olesen et al. NEW ENGLAND JOURNAL OF MEDICINE
- On the covariance of two correlated log-odds ratios
- (2012) Pantelis G. Bagos STATISTICS IN MEDICINE
- Indirect comparison studies – are they useful? Insights from the novel oral anticoagulants for stroke prevention in atrial fibrillation
- (2012) Torben Larsen et al. THROMBOSIS AND HAEMOSTASIS
- Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: Resolving uncertainties in routine practice
- (2012) Gregory Y. H. Lip et al. THROMBOSIS AND HAEMOSTASIS
- Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis
- (2012) L. H. Rasmussen et al. BMJ-British Medical Journal
- Chronic Kidney Disease Is Associated With the Incidence of Atrial Fibrillation
- (2011) Alvaro Alonso et al. CIRCULATION
- Safety and Efficacy of the Oral Direct Factor Xa Inhibitor Apixaban in Japanese Patients With Non-Valvular Atrial Fibrillation
- (2011) Satoshi Ogawa et al. CIRCULATION JOURNAL
- Warfarin in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease
- (2011) R. G. Hart et al. Clinical Journal of the American Society of Nephrology
- Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment
- (2011) K. A. A. Fox et al. EUROPEAN HEART JOURNAL
- Severe Renal Impairment and Stroke Prevention in Atrial Fibrillation
- (2011) Ricarda Marinigh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients
- (2011) Arlene Gallagher et al. THROMBOSIS AND HAEMOSTASIS
- Chronic kidney disease and prevalent atrial fibrillation: The Chronic Renal Insufficiency Cohort (CRIC)
- (2010) Elsayed Z. Soliman et al. AMERICAN HEART JOURNAL
- Warfarin Dosing in Patients With Impaired Kidney Function
- (2010) Nita A. Limdi et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Influence of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate
- (2010) Joachim Stangier et al. CLINICAL PHARMACOKINETICS
- Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation
- (2010) Stuart Connolly et al. THROMBOSIS AND HAEMOSTASIS
- Metabolism and Excretion of Rivaroxaban, an Oral, Direct Factor Xa Inhibitor, in Rats, Dogs, and Humans
- (2009) C. Weinz et al. DRUG METABOLISM AND DISPOSITION
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More